Intensive glucose control and macrovascular outcomes in type 2 diabetes
By F. Turnbull, C. Abraira, R. Anderson, R. Byington, J. Chalmers, W. Duckworth, G. Evans, H. Gerstein, Rury R. Holman, Thomas E. Moritz and 6 more. Diabetologia, 2009
1,096 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/909b4629bdc9f72dd3753c4e34905a5df78ced21
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
- D. Mozaffarian
- M. Woodward
- G. Bakris
- I. Graham
- R. Bergenstal
- L. Rydén
- Antonio Ceriello
- Silvio E. Inzucchi
Citations in the corpus
- Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials (2011, background): “Several meta-analyses evaluating the effect of intensive glucose lowering in people with diabetes are currently available. However, these published meta-analyses”
- 6. Glycemic Targets: Standards of Medical Care in Diabetes-2021. (2021, background): “effects across studies was noted, which may reflect differences in glycemic targets, therapeutic approaches, and, importantly, population characteristics (53).”
- The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. (2013, background): “None of these individual studies showed a significant reduction of the composite endpoint of combined CVD events, but a number of later meta-analyses have documented that more intensive glycaemic control is likely to reduce non-fatal coronary events and myocardial infarction, as well as nephropathy,”
- The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis (2013, background): “Several meta-analyses of randomized trials of intensive versus moderate glucose lowering in diabetic patients have shown significant reduction in the risk of myocardial infarction and other major cardiovascular events [56–58].”